TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nord Vacc Läkemedel AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
7,455
|
6,102
|
4,530 |
Financial expenses |
106
|
11
|
34 |
Earnings before taxes |
-10,373
|
-709
|
-2,983 |
EBITDA |
-10,230
|
-972
|
-2,798 |
Total assets |
5,166
|
8,100
|
4,767 |
Current assets |
5,122
|
6,468
|
2,996 |
Current liabilities |
1,865
|
1,360
|
3,195 |
Equity capital |
324
|
534
|
551 |
- share capital |
477
|
446
|
459 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
6.3%
|
6.6%
|
11.6% |
Turnover per employee |
3,728
|
2,034
|
1,510 |
Profit as a percentage of turnover |
-139.1%
|
-11.6%
|
-65.8% |
Return on assets (ROA) |
-198.7%
|
-8.6%
|
-61.9% |
Current ratio |
274.6%
|
475.6%
|
93.8% |
Return on equity (ROE) |
-3201.5%
|
-132.8%
|
-541.4% |
Change turnover |
920
|
1,708
|
823 |
Change turnover % |
14%
|
39%
|
22% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.